Washington

The Health Care Authority (HCA) revised the Emergency COVID-19 Fee Schedule provider billing guidelines under COVID-19 for Apple Health.  

Also in Washington, the Pharmacy and Therapeutics (P&T) Committee and Drug Utilization Review (DUR) Board will be meeting on June 15th to review drug classes for the Washington PDL, and for the DUR Board to review drug classes for the Apple Health (Medicaid) PDL. This meeting will be held by Zoom webinar only. You will need to register for the webinar to receive the meeting link.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.